Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1

NCT03738878 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT03738878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03738878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Terminated
Start date
November 15, 2018
Completion date
December 1, 2024
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension